Document is current
Any future updates will be listed below
-
Authors
Occhi, G. https://orcid.org/0000-0003-4065-4677
Voltan, G. https://orcid.org/0000-0002-3628-0492
Chiloiro, S. https://orcid.org/0000-0001-9241-2392
Bianchi, A. https://orcid.org/0000-0002-4896-5499
Maffei, P. https://orcid.org/0000-0002-1717-263X
Dassie, F. https://orcid.org/0000-0003-1757-5399
Mantovani, G. https://orcid.org/0000-0002-9065-3886
Del Sindaco, G. https://orcid.org/0000-0002-9050-0150
Ferone, D. https://orcid.org/0000-0002-1410-6143
Gatto, F. https://orcid.org/0000-0002-5062-9208
Losa, M. https://orcid.org/0000-0001-7810-8247
Cannavò, S. https://orcid.org/0000-0001-8779-7283
Scaroni, C. https://orcid.org/0000-0001-9396-3815
Ceccato, F. https://orcid.org/0000-0003-1456-8716
,
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 13 May 2024
Accepted: 10 January 2025
First Online: 22 January 2025
Declarations
:
: Filippo Ceccato: PhD grant by Novartis Pharma. Pietro Maffei: consultancy fees or Principal Investigator by Recordati, Pfizer, Camurus. Diego Ferone: honoraria for lectures or advisory boards from Recordati, Ipsen, Novartis-AAA, as well as research grants from Camurus and Pfizer. Federico Gatto: honoraria for lectures, manuscript writing, educational events, and consultancy from Pfizer and Recordati. All other authors declare that they have no conflicts of interest that might be perceived as influencing the impartiality of the reported research.
